HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $189.1 million versus the consensus estimate of $184.71 million.

GUIDANCE:

HealthEquity sees FY2022 EPS of $1.45-$1.50, versus the consensus of $1.49. HealthEquity sees FY2022 revenue of $755-765 million, versus the consensus of $762.75 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.